News
NRSNW
0.0055
0.00%
0.0000
Weekly Report: what happened at NRSNW last week (1109-1113)?
Weekly Report · 4d ago
Weekly Report: what happened at NRSNW last week (1102-1106)?
Weekly Report · 11/09 09:56
Weekly Report: what happened at NRSNW last week (1026-1030)?
Weekly Report · 11/02 09:56
Weekly Report: what happened at NRSNW last week (1019-1023)?
Weekly Report · 10/26 09:56
NeuroSense Therapeutics Files U.S. Patent Application Covering Methods Of Treating Traumatic Brain Injury And Related Central Nervous System Injuries With Combination Of Ciprofloxacin And Celecoxib
Benzinga · 10/19 12:28
Weekly Report: what happened at NRSNW last week (1012-1016)?
Weekly Report · 10/19 09:56
NeuroSense Appeals Nasdaq Delisting Determination, Hearing Date Set For Nov. 10
NASDAQ · 10/14 09:17
NeuroSense Therapeutics Announces Nasdaq Hearings Panel Date Of November 10; Minimum Bid Price Compliance Already Regained; Sees PrimeC Milestones In December And Q1 2027
Benzinga · 10/13 12:38
Weekly Report: what happened at NRSNW last week (1005-1009)?
Weekly Report · 10/12 10:00
Weekly Report: what happened at NRSNW last week (0928-1002)?
Weekly Report · 10/05 09:59
Weekly Report: what happened at NRSNW last week (0921-0925)?
Weekly Report · 09/28 09:56
NeuroSense H1 Net Loss Narrows; Targets December NDS Filing For PrimeC In ALS
NASDAQ · 09/28 07:40
NeuroSense Provides Business Update and Progress for the First Half of 2026
PR Newswire · 09/25 20:30
Weekly Report: what happened at NRSNW last week (0914-0918)?
Weekly Report · 09/21 09:56
Weekly Report: what happened at NRSNW last week (0907-0911)?
Weekly Report · 09/14 10:00
Weekly Report: what happened at NRSNW last week (0831-0904)?
Weekly Report · 09/07 09:55
NeuroSense Unveils Accelerated, Capital-Efficient PrimeC Development Strategy In ALS
NASDAQ · 09/03 13:25
Weekly Report: what happened at NRSNW last week (0824-0828)?
Weekly Report · 08/31 10:00
Weekly Report: what happened at NRSNW last week (0817-0821)?
Weekly Report · 08/24 10:01
Weekly Report: what happened at NRSNW last week (0810-0814)?
Weekly Report · 08/17 10:02
More
Webull provides a variety of real-time NRSNW stock news. You can receive the latest news about Neurosense Therapeutics Ltd through multiple platforms. This information may help you make smarter investment decisions.
About NRSNW
NeuroSense Therapeutics Ltd is an Israel-based clinical-stage pharmaceutical company. The Company is active in field of drug development and treatment offers Amyotrophic Lateral Sclerosis (ALS) patients, as well as other neurodegenerative diseases. The Company's lead product candidate, PrimeC, is an oral formulation of a fixed dose combination composed of a specific ratio of drugs. In addition to PrimeC, the Company has initiated research and development efforts in Alzheimer's disease and Parkinson's disease